RA
IDXX icon

Rise Advisors’s Idexx Laboratories IDXX Stock Holding History

Rise Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
553
+4
+0.7% +$2.24K 0.08% 83
2026
Q1 		$310K Buy
549
+2
+0.4% +$1.28K 0.11% 64
2025
Q4 		$370K Sell
547
-4
-0.7% -$2.72K 0.13% 58
2025
Q3 		$352K Sell
551
-11
-2% -$6.68K 0.13% 63
2025
Q2 		$301K Buy
562
+21
+4% +$10K 0.12% 68
2025
Q1 		$227K Sell
541
-2
-0.4% -$868 0.1% 82
2024
Q4 		$224K Sell
543
-22
-4% -$9.65K 0.11% 80
2024
Q3 		$285K Sell
565
-2
-0.4% -$972 0.14% 68
2024
Q2 		$276K Buy
567
+194
+52% +$97.4K 0.15% 71
2024
Q1 		$201K Buy
373
+49
+15% +$26.8K 0.11% 92
2023
Q4 		$180K Hold
324
– – 0.13% 73
2023
Q3 		$142K Buy
324
+39
+14% +$19.4K 0.11% 75
2023
Q2 		$143K Hold
285
– – 0.11% 81
2023
Q1 		$143K Sell
285
-1
-0.3% -$479 0.11% 84
2022
Q4 		$117K Sell
286
-12
-4% -$4.66K 0.09% 91
2022
Q3 		$97K Hold
298
– – 0.08% 93
2022
Q2 		$105K Hold
298
– – 0.11% 90
2022
Q1 		$163K Sell
298
-1
-0.3% -$526 0.15% 73
2021
Q4 		$197K Buy
+299
New +$188K 0.19% 65

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Rise Advisors's IDXX Position: Q2 2026 in Review

Rise Advisors increased its Idexx Laboratories (IDXX) stake by 0.73% in Q2 2026, buying an estimated $2.24K and bringing the position to 553 shares worth $291K. The position accounts for 0.08% of the portfolio, ranked #83.

Rise Advisors first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $370K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Rise Advisors held 553 shares of Idexx Laboratories worth $291K as of Q2 2026.
  • Rise Advisors bought 4 Idexx Laboratories shares in Q2 2026, an estimated $2.24K.
  • Idexx Laboratories made up 0.08% of Rise Advisors's portfolio in Q2 2026, its #83 holding.
  • Rise Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Rise Advisors's Idexx Laboratories position peaked at $370K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Rise Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.